Clinical Trials on Breast Cancer Metastatic Breast Cancer in Colombia
Total 2382 results
-
Canadian Cancer Trials GroupAstraZenecaCompletedMetastatic Breast CancerCanada
-
Zetagen Therapeutics, IncRecruitingMetastatic Breast Cancer in the SpineCanada
-
Georgetown UniversityPfizerActive, not recruitingMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone Receptor Positive Breast CancerUnited States
-
Medstar Health Research InstituteGenentech, Inc.TerminatedHER-2 Positive Metastatic Breast CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Bayer; Novartis Pharmaceuticals; Rutgers Cancer...CompletedMetastatic Breast CancerUnited States
-
Canadian Cancer Trials GroupOncolytics BiotechCompletedMetastatic Breast CancerCanada
-
Sidney Kimmel Comprehensive Cancer Center at Johns...PfizerActive, not recruitingMetastatic Breast CancerUnited States
-
Duke UniversityGenentech, Inc.; Novartis PharmaceuticalsCompletedMetastatic Breast CancerUnited States
-
Dana-Farber Cancer InstituteJohns Hopkins University; National Cancer Institute (NCI); Gateway for Cancer... and other collaboratorsRecruitingBreast Cancer | Metastatic Breast Cancer | HER2-positive Breast CancerUnited States
-
Georgetown UniversityTyme, IncTerminatedBreast Cancer | Metastatic Breast Cancer | Hormone Receptor Positive Breast CarcinomaUnited States
-
CelgeneCompletedBreast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Breast Tumor | Cancer of the Breast | Triple-negative Metastatic Breast Cancer | Estrogen Receptor- Negative Breast Cancer | HER2- Negative Breast Cancer | Progesterone Receptor- Negative...United States, United Kingdom, Italy, Germany, Spain, Canada, Portugal, Australia, Austria, Greece, Brazil, France
-
CelgeneTerminated
-
University of Alabama at BirminghamSusan G. Komen Breast Cancer Foundation; Daiichi Sankyo UK Ltd.; Triple Negative...CompletedBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Stage IV Breast CancerUnited States
-
Eli Lilly and CompanyCompletedMetastatic Breast CancerUnited States, Spain, Belgium, France
-
AstraZenecaCompletedAdvanced Breast Cancer | Metastatic Breast CancerBelgium, Turkey, Canada, Poland, Romania, Hungary, France, Czechia
-
SCRI Development Innovations, LLCNovartisCompletedMetastatic Breast CancerUnited States
-
SCRI Development Innovations, LLCBristol-Myers Squibb; BayerCompletedMetastatic Breast CancerUnited States
-
SCRI Development Innovations, LLCEisai Inc.CompletedMetastatic Breast CancerUnited States
-
Ontario Clinical Oncology Group (OCOG)AstraZenecaCompleted
-
CelgeneCompletedMetastatic Breast CancerUnited States
-
Celgene CorporationWithdrawnMetastatic Breast CancerUnited States
-
Genentech, Inc.Completed
-
PfizerCompletedAdvanced Breast Cancer | Metastatic Breast CancerUnited States, Canada
-
University of California, San FranciscoDana-Farber Cancer Institute; Translational Breast Cancer Research ConsortiumCompletedMetastatic Breast Cancer | Hormone Receptor PositiveUnited States
-
Eli Lilly and CompanyGenentech, Inc.CompletedMetastatic Breast Cancer | Locally Advanced Breast CancerUnited States
-
National Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerCanada
-
Enzon Pharmaceuticals, Inc.TerminatedMetastatic Breast CancerUnited States
-
GlaxoSmithKlineCompletedMetastatic Breast Cancer | Neoplasms, BreastUnited States
-
Athenex, Inc.CompletedMetastatic Breast CancerArgentina, Chile, Colombia, Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Panama, Peru
-
Eli Lilly and CompanyCompleted
-
AstraZenecaDaiichi Sankyo Co., Ltd.; Daiichi Sankyo Company, LimitedActive, not recruitingMetastatic Breast CancerBelgium, United States, Taiwan, Korea, Republic of, Brazil, Russian Federation, Canada, Australia, France, Mexico
-
Hoffmann-La RocheRoche Pharma AGCompletedMetastatic Breast CancerItaly, Spain, Canada, United States, Belgium, France, Germany
-
R-PharmUS Oncology ResearchCompletedMetastatic Breast CancerUnited States
-
Nektar TherapeuticsCompletedMetastatic Breast Cancer | Locally Recurrent Breast CancerUnited States, Spain, Korea, Republic of, Canada, United Kingdom, Germany, France, Netherlands, Belgium, Italy, Russian Federation
-
University of Alabama at BirminghamJohns Hopkins University; Georgetown University; University of Chicago; University... and other collaboratorsActive, not recruitingMetastatic Breast Cancer | Leptomeningeal DiseaseUnited States
-
AstraZenecaCompletedMetastatic Breast Cancer | Locally Advanced Breast CancerSweden, United States, Russian Federation, South Africa, United Kingdom, Germany, Hungary, Canada, Belgium, Denmark, Israel, Argentina, France, Brazil, Spain
-
Stemline Therapeutics, Inc.RecruitingBreast Cancer | Metastatic Breast CancerUnited States
-
US Oncology ResearchBristol-Myers SquibbCompleted
-
US Oncology ResearchOrtho Biotech, Inc.; Tibotec Pharmaceutical LimitedCompleted
-
Hoffmann-La RocheRecruitingMetastatic Breast CancerUnited States, Korea, Republic of, Spain, Canada, Brazil, China, Singapore, Turkey, India, Argentina, Australia, Belgium, Finland, Hong Kong, South Africa, Italy, United Kingdom, Poland, Taiwan, Colombia, France, Germany, Mexico
-
US Oncology ResearchBristol-Myers Squibb; PfizerActive, not recruiting
-
Hoffmann-La RocheCompletedMetastatic Breast CancerUnited States, Korea, Republic of, United Kingdom, Italy, Russian Federation, Argentina, Belgium, Brazil, Panama, Germany, Japan, Ukraine, Chile, South Africa, Bulgaria, Romania
-
Elevation OncologyTerminatedMetastatic Breast CancerGermany, Spain, United States, Austria, Belgium, Canada
-
MacroGenicsCompletedHER-2 Positive Breast Cancer | Metastatic NeoplasmUnited States, Spain, Italy, Canada, Israel, Belgium, Germany, Czechia, Austria, Korea, Republic of, Denmark, United Kingdom, Portugal, France, Poland, Netherlands, Finland, Puerto Rico
-
Hoffmann-La RocheCompletedMetastatic Breast CancerUnited States, Korea, Republic of, United Kingdom, Germany, Spain, Taiwan, Australia, Canada, Italy
-
Gilead SciencesCompletedMetastatic Breast CancerUnited States, Spain, United Kingdom, Italy, Canada, France, Germany, Belgium, Netherlands
-
Universidad Nacional de ColombiaFundación Salud de los AndesNot yet recruiting
-
R-PharmCompletedMetastatic Breast CancerItaly, United Kingdom, United States, France, Spain
-
Eli Lilly and CompanyAvailableMetastatic Breast CancerAustralia, Canada, Egypt, India, Italy, Korea, Republic of, Malaysia, Singapore, South Africa, Spain, Switzerland, Taiwan, Thailand, United Kingdom
-
Novartis PharmaceuticalsCompletedAdvanced Metastatic Breast CancerCanada, Italy, Hungary, Taiwan, Turkey, Belgium, Germany, Spain, United States, Singapore, Australia, Korea, Republic of, Hong Kong, Thailand, Lebanon, Bulgaria, France, Russian Federation, Argentina, Brazil, Malaysia, Portugal, Col... and more